BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19893036)

  • 21. Loss of Disabled-2 Expression in Pancreatic Cancer Progression.
    Hocevar BA
    Sci Rep; 2019 May; 9(1):7532. PubMed ID: 31101868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxiredoxin 1 promotes pancreatic cancer cell invasion by modulating p38 MAPK activity.
    Taniuchi K; Furihata M; Hanazaki K; Iwasaki S; Tanaka K; Shimizu T; Saito M; Saibara T
    Pancreas; 2015 Mar; 44(2):331-40. PubMed ID: 25426613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.
    Geismann C; Morscheck M; Koch D; Bergmann F; Ungefroren H; Arlt A; Tsao MS; Bachem MG; Altevogt P; Sipos B; Fölsch UR; Schäfer H; Müerköster SS
    Cancer Res; 2009 May; 69(10):4517-26. PubMed ID: 19435915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein Kinase D1, Reduced in Human Pancreatic Tumors, Increases Secretion of Small Extracellular Vesicles From Cancer Cells That Promote Metastasis to Lung in Mice.
    Armacki M; Polaschek S; Waldenmaier M; Morawe M; Ruhland C; Schmid R; Lechel A; Tharehalli U; Steup C; Bektas Y; Li H; Kraus JM; Kestler HA; Kruger S; Ormanns S; Walther P; Eiseler T; Seufferlein T
    Gastroenterology; 2020 Sep; 159(3):1019-1035.e22. PubMed ID: 32446697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of miR-21 and miR-211 on MMP9 regulation in pancreatic ductal adenocarcinoma: cooperation in invasiveness behaviors?
    Funel N
    Epigenomics; 2015; 7(3):333-5. PubMed ID: 26077422
    [No Abstract]   [Full Text] [Related]  

  • 26. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling.
    Sato N; Matsubayashi H; Abe T; Fukushima N; Goggins M
    Clin Cancer Res; 2005 Jul; 11(13):4681-8. PubMed ID: 16000561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yin Yang-1 suppresses pancreatic ductal adenocarcinoma cell proliferation and tumor growth by regulating SOX2OT-SOX2 axis.
    Zhang JJ; Zhu Y; Zhang XF; Liu DF; Wang Y; Yang C; Shi GD; Peng YP; Zhang K; Tian L; Miao Y; Jiang KR
    Cancer Lett; 2017 Nov; 408():144-154. PubMed ID: 28867247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells.
    Verma A; Guha S; Wang H; Fok JY; Koul D; Abbruzzese J; Mehta K
    Clin Cancer Res; 2008 Apr; 14(7):1997-2005. PubMed ID: 18381937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pancreatic cancer secreted REG4 promotes macrophage polarization to M2 through EGFR/AKT/CREB pathway.
    Ma X; Wu D; Zhou S; Wan F; Liu H; Xu X; Xu X; Zhao Y; Tang M
    Oncol Rep; 2016 Jan; 35(1):189-96. PubMed ID: 26531138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EYA4 functions as tumor suppressor gene and prognostic marker in pancreatic ductal adenocarcinoma through β-catenin/ID2 pathway.
    Mo SJ; Liu X; Hao XY; Chen W; Zhang KS; Cai JP; Lai JM; Liang LJ; Yin XY
    Cancer Lett; 2016 Oct; 380(2):403-412. PubMed ID: 27378242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma.
    Wang W; Chen H; Gao W; Wang S; Wu K; Lu C; Luo X; Li L; Yu C
    Oncol Rep; 2020 Aug; 44(2):637-649. PubMed ID: 32467989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new prognosis prediction model combining TNM stage with MAP2K4 and JNK in postoperative pancreatic cancer patients.
    Liu XD; Zhang ZW; Wu HW; Liang ZY
    Pathol Res Pract; 2021 Jan; 217():153313. PubMed ID: 33341545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase D1 promotes anchorage-independent growth, invasion, and angiogenesis by human pancreatic cancer cells.
    Ochi N; Tanasanvimon S; Matsuo Y; Tong Z; Sung B; Aggarwal BB; Sinnett-Smith J; Rozengurt E; Guha S
    J Cell Physiol; 2011 Apr; 226(4):1074-81. PubMed ID: 20857418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA‑766 inhibits the malignant biological behaviours of pancreatic ductal adenocarcinoma by directly targeting ETS1.
    Li S; Yan G; Yue M; Kang Z; Wang L
    Mol Med Rep; 2019 Feb; 19(2):1380-1387. PubMed ID: 30569091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
    Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
    Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein tyrosine phosphatase nonreceptor type 2 exerts antimetastatic functions in pancreatic ductal adenocarcinoma.
    Zhang S; Wang H; Mao P; Sun Q; Su H; Zhang Y; Shen S; Xu G; Wang L; Zou X; Zhan Q; Lv Y
    Mol Carcinog; 2023 Aug; 62(8):1176-1190. PubMed ID: 37204217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
    Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C
    J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel prognostic biomarker for pancreatic ductal adenocarcinoma: hsa_circ_0001649.
    Jiang Y; Wang T; Yan L; Qu L
    Gene; 2018 Oct; 675():88-93. PubMed ID: 29969694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.